Serum visfatin level as a prognostic marker in colorectal cancer patients: A retrospective cohort study
暂无分享,去创建一个
K. Ghaffarzadegan | S. Mehri | A. Mohammadpour | A. Izanloo | S. Elyasi | M. Jannati | Ranna Raygani
[1] J. M. Gutiérrez-Valverde,et al. Environmental factors and awareness of colorectal cancer in people at familial risk , 2019, Revista latino-americana de enfermagem.
[2] Xiaofei Yan,et al. Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1) , 2017, Cancer Chemotherapy and Pharmacology.
[3] P. Cohen,et al. Insights into the Link Between Obesity and Cancer , 2017, Current Obesity Reports.
[4] E. Świętochowska,et al. Chemotherapy and plasma adipokines level in patients with colorectal cancer. , 2017, Postepy higieny i medycyny doswiadczalnej.
[5] W. Fan,et al. Circulating Resistin Levels and Risk of Colorectal Cancer: A Meta-Analysis , 2016, BioMed research international.
[6] Ahmedin Jemal,et al. Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.
[7] Lingyun Zhang,et al. Regulative Effect of Nampt on Tumor Progression and Cell Viability in Human Colorectal Cancer , 2015, Journal of Cancer.
[8] A. Gamian,et al. Nampt/PBEF/Visfatin Upregulation in Colorectal Tumors, Mirrored in Normal Tissue and Whole Blood of Colorectal Cancer Patients, Is Associated with Metastasis, Hypoxia, IL1β, and Anemia , 2015, BioMed research international.
[9] Min-Ming Xia,et al. Elevated plasma visfatin levels correlate with poor prognosis of gastric cancer patients , 2014, Peptides.
[10] Johanna W Lampe,et al. Long-Chain Omega-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer , 2014, Nutrition and cancer.
[11] L. Šenolt,et al. Early changes in serum visfatin after abdominal surgery: a new pro-inflammatory marker in diagnosis? , 2014, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[12] M. Hedayati,et al. Resistin Effect on HCT-116 Colorectal Cancer Cells Proliferation and Telomer- ase Expression , 2014 .
[13] G. De Pergola,et al. Obesity as a Major Risk Factor for Cancer , 2013, Journal of obesity.
[14] T. Rohan,et al. Visfatin, a potential biomarker and prognostic factor for endometrial cancer. , 2013, Gynecologic oncology.
[15] Eun Sook Kim,et al. Visfatin stimulates proliferation of MCF-7 human breast cancer cells , 2010, Molecules and cells.
[16] T. Matsuda,et al. Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer , 2010, Cancer science.
[17] H. Randeva,et al. Obesity and prostate cancer: a role for adipokines. , 2007, European urology.
[18] R. Busse,et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin , 2006, Diabetologia.
[19] M. Fasshauer,et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. , 2005, Diabetes.
[20] A. Vidal-Puig,et al. Visfatin: the missing link between intra-abdominal obesity and diabetes? , 2005, Trends in molecular medicine.
[21] M. Matsuda,et al. Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin , 2005, Science.
[22] I McNiece,et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor , 1994, Molecular and cellular biology.
[23] R. Gebhardt,et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. , 2010, Biochemical and biophysical research communications.
[24] J. Flier,et al. 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2548–2556 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2004-0395 , 2022 .